ATP8B3 has been utilized in constructing a lung adenocarcinoma risk signature,[38] and studies have shown that ATP8B3 acts as a negative regulator of cancer stemness.[39] This further underscores the multifaceted roles these Golgi-related genes play in cancer progression and their potential utility as biomarkers or therapeutic targets. This evidence concerns the gene ATP8B3 and cancer.